A detailed history of Acadian Asset Management LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Acadian Asset Management LLC holds 788,955 shares of JNJ stock, worth $115 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
788,955
Previous 923,650 14.58%
Holding current value
$115 Million
Previous $135 Million 5.29%
% of portfolio
0.4%
Previous 0.42%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$145.48 - $167.38 $19.6 Million - $22.5 Million
-134,695 Reduced 14.58%
788,955 $128 Million
Q2 2024

Aug 06, 2024

BUY
$144.38 - $157.78 $29.8 Million - $32.6 Million
206,671 Added 28.83%
923,650 $135 Million
Q1 2024

May 10, 2024

SELL
$155.22 - $162.74 $5.1 Million - $5.35 Million
-32,863 Reduced 4.38%
716,979 $113 Million
Q4 2023

Feb 13, 2024

SELL
$145.6 - $158.88 $4.24 Million - $4.62 Million
-29,096 Reduced 3.74%
749,842 $118 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $19.1 Million - $21.4 Million
-122,784 Reduced 13.62%
778,938 $121 Million
Q2 2023

Aug 07, 2023

SELL
$154.35 - $166.11 $3.33 Million - $3.58 Million
-21,544 Reduced 2.33%
901,722 $149 Million
Q1 2023

May 11, 2023

SELL
$151.05 - $180.26 $15.7 Million - $18.7 Million
-103,725 Reduced 10.1%
923,266 $143 Million
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $11.3 Million - $12.7 Million
70,544 Added 7.38%
1,026,991 $181 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $5.27 Million - $5.86 Million
32,645 Added 3.53%
956,447 $156 Million
Q2 2022

Aug 09, 2022

SELL
$168.19 - $186.01 $15.7 Million - $17.4 Million
-93,589 Reduced 9.2%
923,802 $164 Million
Q1 2022

May 12, 2022

SELL
$158.14 - $179.59 $4.27 Million - $4.85 Million
-26,989 Reduced 2.58%
1,017,391 $180 Million
Q4 2021

Feb 10, 2022

SELL
$155.93 - $173.01 $22.1 Million - $24.5 Million
-141,684 Reduced 11.95%
1,044,380 $179 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $12.9 Million - $14.4 Million
-80,040 Reduced 6.32%
1,186,064 $192 Million
Q2 2021

Aug 11, 2021

BUY
$159.48 - $171.07 $4.14 Million - $4.44 Million
25,962 Added 2.09%
1,266,104 $209 Million
Q1 2021

May 11, 2021

SELL
$153.07 - $170.48 $2 Million - $2.22 Million
-13,048 Reduced 1.04%
1,240,142 $204 Million
Q4 2020

Feb 11, 2021

BUY
$137.11 - $157.38 $11.2 Million - $12.8 Million
81,464 Added 6.95%
1,253,190 $197 Million
Q3 2020

Nov 09, 2020

SELL
$140.38 - $153.83 $44.7 Million - $48.9 Million
-318,115 Reduced 21.35%
1,171,726 $174 Million
Q2 2020

Aug 12, 2020

BUY
$128.81 - $155.51 $44.9 Million - $54.2 Million
348,500 Added 30.53%
1,489,841 $210 Million
Q1 2020

May 11, 2020

BUY
$111.14 - $153.99 $95.8 Million - $133 Million
861,923 Added 308.47%
1,141,341 $150 Million
Q4 2019

Feb 06, 2020

BUY
$127.5 - $146.44 $1.99 Million - $2.29 Million
15,632 Added 5.93%
279,418 $40.8 Million
Q3 2019

Nov 07, 2019

BUY
$126.95 - $142.14 $2.72 Million - $3.05 Million
21,449 Added 8.85%
263,786 $34.1 Million
Q2 2019

Aug 08, 2019

SELL
$131.15 - $144.24 $45.6 Million - $50.1 Million
-347,500 Reduced 58.91%
242,337 $33.8 Million
Q1 2019

May 09, 2019

BUY
$125.72 - $139.79 $1.59 Million - $1.77 Million
12,629 Added 2.19%
589,837 $82.5 Million
Q4 2018

Feb 07, 2019

SELL
$122.84 - $147.84 $32.4 Million - $39 Million
-263,838 Reduced 31.37%
577,208 $74.5 Million
Q3 2018

Oct 30, 2018

SELL
$121.58 - $142.88 $25.1 Million - $29.5 Million
-206,232 Reduced 19.69%
841,046 $116 Million
Q2 2018

Jul 24, 2018

SELL
$119.4 - $131.76 $5.22 Million - $5.76 Million
-43,739 Reduced 4.01%
1,047,278 $127 Million
Q1 2018

Apr 12, 2018

BUY
$125.1 - $148.14 $8.36 Million - $9.9 Million
66,829 Added 6.53%
1,091,017 $140 Million
Q4 2017

Jan 18, 2018

SELL
$131.22 - $143.62 $3.4 Million - $3.72 Million
-25,928 Reduced 2.47%
1,024,188 $143 Million
Q3 2017

Oct 13, 2017

BUY
$129.47 - $135.38 $136 Million - $142 Million
1,050,116
1,050,116 $137 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.